Northwest Biotherapeutics confirms status of phase III trial of DCVax-L in glioblastoma multiforme Aug. 24, 2015
Prostate cancer vaccine MVI-816 enters phase I/II trial in combination with pembrolizumab Aug. 20, 2015
Phase II study examines combination of pembrolizumab and IL-12 gene therapy in melanoma Aug. 19, 2015
Phase Ib/II trial investigates talimogene laherparepvec with radiotherapy for soft tissue sarcomas Aug. 14, 2015
Merck & Co. and MD Anderson to evaluate pembrolizumab combination therapies for solid tumors Aug. 14, 2015
RSS